San Diego, CA, United States of America

Fei Hong

This inventor holds 62 USPTO granted patents and 18 published patent applications, plus 21 CIPO patents and 23 EPO patents, primarily in Aminoacyl tRNA Synthetases (CPC class C07K). Top assignees: Atyr Pharma, Inc., Pangu Biopharma Limited, Atye Pharma, Inc.. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fei Hong. Retrieved from https://idiyas.com/inventor/fei-hong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 62 

% Patents Active = 93.5


 

Average Co-Inventor Count = 7.9

ph-index = 9

Forward Citations = 345(Granted Patents)

Forward Citations (Not Self Cited) = 216(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Aminoacyl tRNA Synthetases
Therapeutic Compositions
Diagnostic Compositions
Protein Fragments
Inflammation Modulation
Cysteinyl-tRNA Synthetase
Histidyl-tRNA Synthetases
Threonyl-tRNA Synthetases
Isoleucyl tRNA Synthetases
Leucyl-tRNA Synthetases
Valyl-tRNA Synthetases
Phenylalanyl-tRNA Synthetases
62 patents (USPTO):Explore Patents

Title: The Innovative Work of Fei Hong: A Leader in Therapeutic Discoveries

Introduction

Fei Hong, based in San Diego, California, is a prominent inventor known for his significant contributions in the field of biotechnology, particularly in therapeutic and diagnostic applications. With an impressive portfolio of 62 patents, Hong has made groundbreaking discoveries that advance our understanding and treatment of diseases.

Latest Patents

Fei Hong's recent innovations include the discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Cysteinyl-tRNA synthetase. This invention provides compositions that comprise newly identified protein fragments of aminoacyl-tRNA synthetases, along with the polynucleotides that encode these fragments. The related agents and methods of use further emphasize its relevance in diagnostic, drug discovery, and therapeutic applications.

Additionally, Hong has developed similar compositions related to Histidyl-tRNA synthetases, which also focus on the newly recognized protein fragments of aminoacyl-tRNA synthetases. These inventions serve critical roles in enhancing research and therapeutic applications.

Career Highlights

Throughout his career, Fei Hong has collaborated with leading companies in the biotech industry, notably Atyr Pharma, Inc. and Pangu Biopharma Limited. His work has consistently focused on pushing the boundaries of scientific research and promoting innovative solutions to complex medical challenges.

Collaborations

During his time in the industry, Fei Hong has worked alongside talented professionals, including his coworkers Leslie Ann Greene and Kyle P Chiang. These collaborations reflect his commitment to teamwork and collective advancement in the field of biotechnology.

Conclusion

Fei Hong stands out as an influential inventor who continues to shape the future of therapeutic and diagnostic applications through his innovative discoveries. With a strong background in research and collaboration, his work significantly contributes to the ongoing development of effective medical treatments and diagnostics. As his portfolio grows, the impact of his inventions will undoubtedly resonate within the scientific community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…